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Women Have a Lower Prevalence of Structural Heart
Disease as a Precursor to Sudden Cardiac Arrest
The Ore-SUDS (Oregon Sudden Unexpected Death Study)
Sumeet S. Chugh, MD,* Audrey Uy-Evanado, MD,* Carmen Teodorescu, MD, PHD,*
Kyndaron Reinier, PHD, MPH,* Ronald Mariani, EMT-P,* Karen Gunson, MD,‡
Jonathan Jui, MD, MPH†
Los Angeles, California; and Portland, Oregon
Objectives Our aim was to utilize a community-based approach to identify sex-related differences in risk factors for sudden
cardiac arrest (SCA).
Background There are significant sex-based differences in prevalence and manifestation of SCA. Any differences related to
predictors of SCA in women versus men are likely to have implications for risk stratification and prevention.
Methods The Ore-SUDS (Oregon Sudden Unexpected Death Study) is an ongoing prospective investigation of SCA in the
Portland, Oregon, metropolitan area (population approximately 1 million). All cases meeting criteria for SCA
were ascertained using multiple sources. Medical records were reviewed to identify clinical conditions that may
contribute to SCA risk, and comparisons were made between male and female SCA cases using Pearson’s chi-
square tests for categorical variables, t tests for continuous variables, and multivariate logistic regression analysis.
Results During 2002 to 2007, 1,568 adult SCA cases were identified (women 36% vs. men 64%; p  0.0001) and
women were older (mean age 71  14 years vs. 65  14 years, p  0.0001). There were no significant sex dif-
ferences in prevalence of obesity, dyslipidemia, history of chronic obstructive pulmonary disease/asthma, left
ventricular (LV) hypertrophy, or history of myocardial infarction. In multivariate analysis, women were signifi-
cantly less likely to have severe LV dysfunction (odds ratio: 0.51; 95% confidence interval: 0.31 to 0.84) or previ-
ously recognized coronary artery disease (odds ratio: 0.34; 95% confidence interval: 0.20 to 0.60) compared
with men.
Conclusions Women were significantly less likely than men to have a diagnosis of structural heart disease (LV dysfunction or
coronary artery disease) before SCA. These findings suggest that fewer women may be eligible for prophylactic
implantable cardioverter-defibrillator placement based on current guidelines and therefore may not have equal
opportunity for prevention. Enhancement of SCA risk stratification may have even higher importance for
women. (J Am Coll Cardiol 2009;54:2006–11) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.038f
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mudden cardiac arrest (SCA) remains a major public health
roblem, claiming at least 250,000 lives in the U.S. on an
nnual basis (1,2). There are significant sex-related differ-
nces in prevalence and manifestation of SCA. The condi-
ion manifests more commonly and at younger ages in men,
mplying a protection conferred by female sex (1,3). Preva-
ence of coronary artery disease (CAD), the diagnosis most
ommonly associated with SCA, is significantly lower in
rom the *Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California;
nd the Departments of †Emergency Medicine and ‡Pathology, Oregon Health and
cience University, Portland, Oregon. This study was supported, in part, by the
ational Heart, Lung, and Blood Institute grant R01HL088416 to Dr. Chugh. Dr.
hugh holds the Pauline and Harold Price Endowed Chair for Cardiac Electrophys-
ology Research at the Cedars-Sinai Medical Center, Los Angeles, California.O
Manuscript received February 25, 2009; revised manuscript received June 18, 2009,
ccepted July 21, 2009.emale SCA (4,5). A recent autopsy study in a group 35 to
4 years of age found significantly higher rates of unex-
lained sudden deaths in women compared with men (6).
emale SCA cases are more likely to present with pulseless
lectrical activity (PEA) or asystole compared with male
ases (1,7). Since rates of successful resuscitation are signif-
cantly lower in PEA/asystole versus ventricular tachycardia/
brillation (2% vs. 25%, respectively [1,8]), there are impli-
ations for survival from SCA in women.
Due to these significant sex-based differences, the possi-
ility that women may have a different SCA risk profile
rom men merits consideration. Available comparisons of
CA risk predictors between the sexes would suggest that
oronary disease-related risk factors are common to both
en and women (4). However, an earlier analysis of the
re-SUDS (Oregon Sudden Unexpected Death Study)
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November 24, 2009:2006–11 Sex and Predictors of Sudden Deatherformed in a small number of patients suggested that
omen who suffer SCA may have a lower prevalence of
evere left ventricular (LV) dysfunction (9), the major risk
tratification variable currently utilized in clinical practice.
iven the reported lower rates of CAD and higher rates of
nexplained sudden death among female SCA cases, we
ypothesized that sex-specific risk factors would be identi-
ed among cases of SCA in the general population. As part
f the ongoing prospective, population-based Ore-SUDS
tudy, we performed a larger, comprehensive comparison
etween women and men of all available clinical risk
redictors of SCA.
ethods
ase ascertainment. Detailed methods regarding the on-
oing Ore-SUDS study have been published earlier (1,3,9).
ases of SCA in the Portland, Oregon, metropolitan area
population approximately 1 million) were identified be-
ween February 1, 2002, and January 31, 2007, using
ultiple sources. During 2002 to 2005, cases of out-of-
ospital SCA were identified from emergency medical
ervices (approximately 70%), the medical examiner’s office
approximately 25%), and local emergency rooms (approx-
mately 5%). During 2005 to 2007, ascertainment was
imited to SCA cases with attempted resuscitation or those
hat were investigated by the medical examiner.
SCA was defined as a sudden unexpected pulseless
ondition occurring within 1 h of symptom onset (witnessed
vents) or within 24 h of having last been observed alive and
ymptom-free (unwitnessed) (10). Furthermore, the loca-
ion of SCA had to be in an out-of-hospital or emergency
oom setting. A diagnosis of SCA was assigned after
n-house adjudication by 3 physicians who evaluated cir-
umstances of cardiac arrest and all available clinical data.
urvivors of SCA were included. Subjects with chronic
erminal illnesses (e.g., cancer), known noncardiac causes of
udden death (e.g., pulmonary embolism, cerebrovascular
ccident), traumatic deaths, and overdoses were excluded.
his study was approved by the Institutional Review Board
f Oregon Health and Science University as well as all other
articipating hospitals and health systems.
ata collection. SCA cases included in the analysis of
emographics and arrest circumstances were at least 35 years
ld at the time of event; analysis of clinical characteristics
as restricted to the majority subset with medical records
vailable. Records were retrospectively reviewed for demo-
raphic information as well as detailed clinical history of
AD, left ventricular mass (LVM)/LV hypertrophy, hyper-
ension, smoking, diabetes, dyslipidemia, obesity, and other
omorbidities. When available and unrelated to the SCA
vent, electrocardiograms (ECGs), echocardiograms, coro-
ary angiograms, and laboratory data were reviewed as well
s all available autopsy data. Information regarding LV
ystolic function (left ventricular ejection fraction [LVEF])
as obtained from an echocardiogram, LV angiogram, cr multigated acquisition scan
erformed before and unrelated
o SCA.
efinitions of clinical variables.
V systolic function was classified
sing LVEF as follows: normal
LVEF 55%), mild-moderate
V dysfunction (LVEF 36% to
4%), and severe LV dysfunction
LVEF 35%). LVM was calcu-
ated from echocardiograms before
rrest using the American Society
f Echocardiography modified
quation (11), and LVM was in-
exed to body surface area. LV
ypertrophy was defined as LVM/
ody surface area 134 g/m2 for
en and 110 g/m2 for women
12). Definite CAD was defined
s 50% stenosis of a major cor-
nary artery on angiogram or post-
ortem examination; history of
ercutaneous coronary intervention or coronary artery bypass
rafting; physician report of myocardial infarction; pathologic
waves on ECG; or myocardial infarction history determined
y any 2 of the following: ischemic symptoms, ECG changes,
r positive troponins/creatinine kinase-MB. The QT interval
as obtained from a standard 12-lead pre-arrest ECG, with
easurements conducted manually using calipers, and cor-
ected using Bazett’s formula (QTc). Sex-specific categories
f QTc were also used: men 430 ms (normal), 431 to 450
s (borderline), and 450 ms (abnormal); women 450
s (normal), 451 to 470 ms (borderline), and 470 ms
abnormal).
Hypertension was defined as clinical history of hyperten-
ion and diabetes mellitus (DM) as clinical history of DM
r use of antidiabetic medications. Dyslipidemia was de-
ned as clinical history or use of lipid-lowering medications.
esponse time was defined as the time from dispatch of
mergency medical personnel to their arrival on the scene.
eturn of spontaneous circulation after resuscitation was
efined as a return of a palpable pulse in conjunction with a
ystolic blood pressure of at least 60 mm Hg. Survival to
ospital discharge was defined as discharge to home or a
oncritical care facility.
tatistical analysis. Statistical analyses were performed
sing SAS version 9.1 (SAS Institute Inc., Cary, North
arolina). Demographic and clinical characteristics of male
nd female SCA cases were summarized using frequencies
or categorical variables and means with SDs for continuous
ariables, and sex differences were examined using Pearson’s
hi-square tests for categorical variables or t tests for
ontinuous variables. Sex differences were also evaluated and
djusted for age using the Cochran-Mantel-Haenszel test
or categorical variables and analysis of covariance for
Abbreviations
and Acronyms
CAD  coronary artery
disease
CI  confidence interval
DM  diabetes mellitus
ICD  implantable
cardioverter-defibrillator
LV  left ventricle/
ventricular
LVEF  left ventricular
ejection fraction
LVM  left ventricular
mass
PEA  pulseless electrical
activity
QTc  corrected QT
interval
SCA  sudden cardiac
arrestontinuous variables. Multiple logistic regression was per-
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Sex and Predictors of Sudden Death November 24, 2009:2006–11ormed using variables found to be significant in univariate
omparisons. For all analyses, a value of p  0.05 was
onsidered statistically significant.
esults
ubject demographics and circumstances of SCA. Dur-
ng the 5-year period of ascertainment, 1,568 SCA cases
ere identified (Table 1). The majority of cases were male
ubjects (1,012 men, 64% vs. 556 women, 36%; p 
.0001), and women were older (mean age 71 14 years vs.
5  14 years, p  0.0001) (Table 1). Information on
resenting arrhythmia at the time of arrest was available in
06 (70%) men and 356 (64%) women (Table 1). Ventric-
lar fibrillation or ventricular tachycardia was more com-
only observed among men and PEA/asystole among
omen (p  0.0001). Sex differences observed in the
resenting rhythm remained significant after adjusting for
ge (p 0.0004). Women were more likely to have a return
f spontaneous circulation during resuscitation (women
5% and men 21%, p  0.04). However, there were no
ignificant sex differences in the proportion of arrests that
ere witnessed, in response time, or in rates of survival to
ospital discharge (p  0.25) (Table 1).
ex-based comparisons of clinical characteristics. Of the
otal 1,568 cases, 1,258 had medical records available (805
en [80%] and 453 women [81%]). Men were more likely
o be active or former smokers compared with women (42%
emographics and Cardiac Arrest Circumstances ofen and Women Age >35 Year W th SCA,ortl , Orego , M tropolitan Area, Febru ry 2002o January 2007 (n  1,568)
Table 1
Demographics and Cardiac Arrest Circumstances of
Men and Women Age >35 Years With SCA,
Portland, Oregon, Metropolitan Area, February 2002
to January 2007 (n  1,568)
Men Women p Value*
n (%) 1,012 (64.5) 556 (35.5) 0.0001
Age, yrs 64.9 14.5 71.0 14.5 0.0001
Age categories, yrs
35–54 294 (29.0) 97 (17.4) 0.0001
55–74 436 (43.1) 205 (36.9)
75 282 (27.9) 254 (45.7)
Presenting rhythm
VF/VT 335 (47.4) 117 (32.8) 0.0001
PEA 167 (23.7) 101 (28.4)
Asystole 193 (27.3) 126 (35.4)
Other† 11 (1.6) 12 (3.4)
Missing‡ 306 200
ROSC 210 (20.8) 141 (25.4) 0.04
STHD 74 (7.3) 47 (8.4) 0.42
Witnessed status
Witnessed 515 (51.3) 262 (48.2) 0.25
Not witnessed 489 (48.7) 281 (51.8)
Missing‡ 8 13
Response time 6.4 3.3 (n  716) 6.5 3.0 (n  379) 0.77
alues are n (%) or mean SD. *p value from Pearson chi-square test for categorical variables and
test for continuous variables; †other presenting rhythms include: paced rhythm, third-degree
eart block, and bradycardia; ‡for variables with missing values, proportions and p values are
alculated using the nonmissing data as the denominator.
PEA  pulseless electrical activity; ROSC  return of spontaneous circulation; SCA  suddenf
ardiac arrest; STHD  survived to hospital discharge; VF/VT  ventricular fibrillation/ventricular
achycardia.s. 36% and 36% vs. 24%, respectively; p 0.0001) (Table 2).
reviously documented CAD was lower in women versus
en (40% vs. 49%; p  0.001), but there were no differ-
nces with respect to history of myocardial infarction (29%
s. 26%; p  0.19) (Table 2). Hypertension and DM were
ore common among women (73% vs. 62%, p  0.0001
nd 40% vs. 34%, p  0.03, respectively). Only 18 subjects
1.1% of the total, n 1,568) had implantable cardioverter-
efibrillators (ICDs) implanted before the event, 14 (1.4%)
en and 4 (0.7%) women (p  0.23). There were no sex
ifferences in the prevalence of history of prior cardiac
rrest, dyslipidemia, obesity, history of chronic obstructive
ulmonary disease or asthma, history of seizure, or presence
f LV hypertrophy (p  0.10).
Records documenting LV function were available in 307
38%) men and 178 (39%) women (Table 2). Women were
ignificantly more likely to have normal LV systolic function
ompared with men (49% vs. 35%), and men were more
ikely to have severe LV systolic dysfunction than women
35% vs. 21%, p  0.001). QTc was significantly longer in
omen compared with men (457 39 ms vs. 444 45 ms;
 0.003).
After adjustment for age, all clinical comparisons in Table
remained consistent, except history of myocardial infarc-
ion, which became significant (p  0.05), and the sex-
pecific QTc categories, which lost significance (p  0.16).
In the multivariate logistic regression analysis, all 1,258
ubjects had information on age, CAD, hypertension, his-
ory of myocardial infarction and DM. LV systolic function
as available for 485 of the 1,258 cases. Table 3 presents the
esults of the logistic model (n  485). Women were
ignificantly less likely to have CAD (odds ratio: 0.34; 95%
onfidence interval [CI]: 0.20 to 0.60) and severe LV
ysfunction (odds ratio: 0.51; 95% CI: 0.31 to 0.84)
ompared with men (Table 3). Hypertension, history of
yocardial infarction, and DM were no longer significantly
ifferent by sex. In a model including QTc (n  223
ubjects with complete data), longer QTc remained associ-
ted with female sex, and the other associations remained
onsistent but the CIs were wider.
iscussion
n this population-based analysis, sex-based comparisons of
otential risk factors for SCA identified 2 distinct clinical
actors that were unique to women who experience SCA.
omen were significantly less likely than men to have
evere LV dysfunction as a precursor to SCA. In addition,
here was a significantly lower likelihood of women having
n established diagnosis of CAD before SCA. These
ndings coincided with trends toward higher prevalence of
M and hypertension in women. There were no significant
ex differences in the mean body mass index or prevalence of
besity, dyslipidemia, history of chronic obstructive pulmo-
ary disease/asthma, or LV hypertrophy. After correction
or age, significant sex differences disappeared for the
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November 24, 2009:2006–11 Sex and Predictors of Sudden Deathex-specific QTc categories that account for underlying
ale-female differences in the QTc interval, but remained
or QTc measured continuously. This may imply that when
he underlying longer QTc in women is taken into account,
Tc does not appear to differentiate female from male SCA
atients. With regard to presenting arrhythmia at the time
f cardiac arrest, ventricular fibrillation or ventricular tachy-
ardia was more commonly observed among men and
EA/asystole among women.
The lower rate of severe systolic LV dysfunction in women
ho experience SCA is a finding with potentially important
mplications. Risk stratification based on degree of LV systolic
ysfunction remains the major current and clinically utilized
ethod of SCA risk stratification. The vast majority of
atients who undergo ICD implantation have some form of
Clinical Characteristics of Men and Women AgeRecords Available, Portland, Oregon, Metropolit2007 (n  1,258)
Table 2
Clinical Charact ristics of M and
Records Available, Portland, Oregon
2007 (n  1,258)
Men
n (%) 805 (64.0)
Age, yrs 66.3 14.3
BMI, kg/m2 29.6 8.2 (n  617)
Obesity‡ 232 (37.6)
Missing§ 188
Smoking
Active 235 (41.8)
Former 203 (36.1)
Nonsmoker 124 (22.1)
Missing§ 243
Documented CAD 396 (49.2)
History of MI 234 (29.1)
History of prior cardiac arrest 22 (2.7)
Hypertension 500 (62.1)
Diabetes mellitus 272 (33.8)
Dyslipidemia 302 (37.5)
COPD/asthma 219 (27.2)
History of seizure 44 (5.5)
Left ventricular hypertrophy 92 (44.7)
Missing§ 599
LV systolic dysfunction
Normal function 108 (35.2)
Mild-moderate dysfunction 90 (29.3)
Severe dysfunction 109 (35.5)
Missing§ 498
Sex-specific QTc categories¶
Normal 110 (40.9)
Borderline 58 (21.6)
Abnormal 101 (37.5)
Missing§ 536
QTc# 444.3 45.4 (n  269)
Values are n (%) or mean SD. *p value from Pearson chi-square test
for age using Cochran-Mantel-Haenszel test for categorical variables a
30 kg/m2; §for variables with missing values, proportions and p v
ventricular (LV) systolic dysfunction defined as normal (ejection fractio
dysfunction (ejection fraction35%); ¶corrected QT interval (QTc) cate
ms (abnormal); women 450 ms (normal), 451 to 470 ms (borderlin
CAD  coronary artery disease; COPD  chronic obstructive pulmoardiomyopathy with evidence of severe LV systolic dysfunc- pion (LVEF 35%). From community-based studies, we and
thers have previously reported that only 25% to 30% of SCAs
ccur in subjects who have severely reduced LV systolic
unction (1,3,9,13,14). Using the existing guidelines for ICD
mplantation, we are likely to miss the opportunity to effectively
isk stratify almost 70% to 75% of individuals who will
xperience SCA, and the current findings suggest that this
umber could be even higher for women.
The significantly lower prevalence of recognized CAD
mong women who experience SCA is a novel finding in a
opulation-based setting. There are several possible expla-
ations. The fact that these results are consistent with
ublished findings among hospitalized survivors of SCA
15) would suggest that this reflects a lower prevalence of
ignificant CAD among female SCA cases. However, the
Years With SCA and Physicianea, February 2002 to Januaryen Age >35 Years Wit SCA and Physician
tropolitan Area, February 2002 to January
Women p Value*
p Value†
(Age-Adjusted)
453 (36.0) 0.0001 —
71.3 14.3 0.0001 —
29.4 10.1 (n  314) 0.73 0.60
120 (38.2) 0.85 0.28
139
107 (36.4) 0.0001 0.0001
71 (24.1)
116 (39.5)
159
180 (39.7) 0.001 0.0005
116 (25.6) 0.19 0.05
8 (1.8) 0.28 0.26
330 (72.8) 0.0001 0.002
180 (39.7) 0.03 0.02
154 (34.0) 0.21 0.18
143 (31.6) 0.10 0.12
29 (6.4) 0.49 0.17
61 (49.2) 0.42 0.41
329
87 (48.9) 0.001 0.001
54 (30.3)
37 (20.8)
275
89 (49.7) 0.05 0.16
24 (13.4)
66 (36.9)
274
56.7 38.8 (n  179) 0.003 0.002
gorical variables and t test for continuous variables; †p value adjusted
lysis of covariance for continuous variables; ‡body mass index (BMI)
re calculated using the nonmissing data as the denominator; left
), mild-moderate dysfunction (ejection fraction 36% to 54%), severe
efined as men430ms (normal), 431 to 450ms (borderline),450
0 ms (abnormal); #corrected using Bazett’s formula.
ease; MI  myocardial infarction; other abbreviations as in Table 1.>35an ArWom
, Me
4
for cate
nd ana
alues a
n 55%
gories dossibility that women without CAD are more likely to be
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Sex and Predictors of Sudden Death November 24, 2009:2006–11uccessfully resuscitated from SCA cannot be ruled out. Other
otential explanations are that consideration of traditional risk
actors may lead to under-recognition of CAD in women (16),
hat physicians pursue a less aggressive management approach
o CAD in women than in men (17), and/or that there are
igher rates of microvascular CAD (as opposed to epicardial
AD) among women (18). While this phenomenon clearly
arrants further investigation, CAD remains the condition
ost commonly associated with SCA. Symptoms related to
AD often prompt health care provider visits and an oppor-
unity for risk stratification and initiation of drug therapy.
herefore, it is also likely that the lower prevalence of recog-
ized CAD among women impedes effective risk stratification
nd prevention of SCA in women.
It is of interest that a recent analysis of a Medicare
opulation sample (1991 to 2005) reported that men were
ignificantly more likely to undergo ICD implantation for
oth primary and secondary prevention of SCA (hazard
atio: 3.15, 95% CI: 2.86 to 3.47, and hazard ratio: 2.44,
5% CI: 2.30 to 2.59, respectively) (19). This same sex
isparity has also been reported in 2 other database analysis
tudies (20,21). A subgroup analysis of MADIT-II (Mul-
icenter Automatic Defibrillator Implantation Trial II) (22)
lso reported lower rates of enrollment in women. However,
omen and men experienced a similar survival benefit from
CD therapy. Therefore, development of methods that
nhance SCA risk stratification in women should become
n even higher priority. This need is underscored by our
dditional findings that the proportion of female SCA cases
as higher than expected. In 2004, in contrast to earlier
tudies that have reported a 25:75 female/male ratio (23,24),
e observed that 40% of all cases were women (1,3). Over
period of 5 years, these findings have been consistent in
he Ore-SUDS study with an average prevalence of 36%.
hile the reasons for this changing trend need to be
valuated in detail, one possibility is that it corresponds to
he altered sex distribution in prevalence of and mortality
ultivariate Odds Ratio Estimates of Clinicalred ctors of Women Versus Men Age >35 Yearsith SCA, Portland, Or gon, tropolita Area,ebruary 2002 to January 2007 (n  485)
Table 3
Multivariate Odds Ratio Estimates of Clinical
Predictors of Women Versus Men Age >35 Years
With SCA, Portland, Oregon, Metropolitan Area,
February 2002 to January 2007 (n  485)
Characteristics Odds Ratio (95% CI)
Age 1.02 (1.00–1.04)
CAD 0.34 (0.20–0.60)
History of MI 1.46 (0.84–2.53)
Hypertension 1.31 (0.81–2.12)
Diabetes mellitus 1.25 (0.84–1.85)
LV systolic dysfunction*
Normal function Reference
Mild-moderate dysfunction 0.91 (0.57–1.45)
Severe dysfunction 0.51 (0.31–0.84)
LV systolic dysfunction defined as normal (ejection fraction 55%), mild-moderate dysfunction
ejection fraction 36% to 54%), and severe dysfunction (ejection fraction 35%).
CAD  coronary artery disease; CI  confidence interval; LV  left ventricular; MI myocardial
nfarction; other abbreviations as in Table 1.rom CAD (25). aIf prevalence of severe LV systolic dysfunction in women
s low and corresponds to lower rates of diagnosed coronary
isease, what are the mechanisms of SCA in the majority of
omen? The established association between CAD risk
actors such as smoking, hypertension, and diabetes is
ommon to both women and men (4). However, there
ppear to be distinct differences in how SCA manifests in
omen. In a post-mortem study, a subgroup of younger
omen tended to have plaque erosion with relatively little
oronary arterial narrowing and less plaque calcium (26).
urthermore, the majority of women (69% in an earlier
rospective study [4]) tend to have no history of cardiac
isease before SCA (5). This could be consistent with
igher rates of vulnerable plaque rupture without pre-
xisting severe stenosis. There are other potential mecha-
isms. Based on higher rates of diastolic heart failure among
omen in the community, it has been suggested that
omen who experience SCA could have a higher prevalence
f LV diastolic dysfunction (with preserved LV systolic
ysfunction) than men (27,28). Our findings that hyperten-
ion and DM were more common in women compared with
en (73% vs. 62%, p  0.0001 and 39% vs. 34%, p  0.03,
espectively) would support the diastolic dysfunction hy-
othesis. There is evidence that common as well as rare gene
ariants may contribute to SCA and that at least some of
hese may be distributed more commonly among women. In
ommunity-based studies, common variants in the SCN5A
ene can increase susceptibility to SCA among women (29),
ut not in men (30). The majority (approximately 70%) of
ll reported cases of the familial or acquired long QT
yndromes are women. Consistent with prior observations,
he QTc was significantly longer in women (31). Women
ere more likely to manifest with PEA compared with men
nd had higher rates of return of spontaneous circulation,
ut there were no differences in rates of survival to hospital
ischarge.
tudy limitations. Based on their design, population-
ased studies of SCA have some limitations that relate
ostly to the fact that all subjects analyzed may not have
niform information available. This is directly attributable
o the fact that a large proportion of patients may have SCA
ithout prior warnings or health care provider visits for
ardiac testing. While prospective cohort studies could
ircumvent this limitation, the incidence of SCA is such
hat the large size of cohort required renders this approach
nfeasible. However, in the present study, availability of
edical records were comparable in men and women (80%
s. 81%). Also, documentation of LV function was available
n 307 (38%) men and 178 (39%) women, further decreas-
ng the likelihood of sex bias in this regard. Nonetheless, it
emains possible that if the entire population were screened
ith echocardiograms, the overall prevalence of LV dys-
unction may be different. Also, while subjects included in our
nalysis constituted the vast majority of SCA cases in the
egion, limiting ascertainment to individuals that underwent
ttempted resuscitation or were investigated by the medical
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onclusions
n this population-based analysis, the proportion of women
ith SCA was higher than anticipated (36% women, 64%
en). However, prevalence of severe LV systolic dysfunc-
ion and previously established CAD were significantly
ower in women versus men. This could, in part, explain the
ower rates of ICD implantation in women. Although the
nderlying pathophysiology and risk factors for SCA in
omen are generally assumed to be similar to men, these
ndings suggest that women may have unique risk predictors.
ince fewer women may be eligible for ICD implantation
ased on LVEF criteria alone, the identification of novel SCA
isk predictors for women becomes an important priority.
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